We fact-checked the hype behind the Eledon Pharmaceuticals Type 1 diabetes treatment
In the words of Leslie Knope: “Diabetes. Let’s dia-beat-this!”
Deep dives into Clinical Trials & Evidence Generation and its impact on healthcare. From Adaptive Trial Design and Clinical Trials to industry-wide shifts, Healthcare Brew covers the essential developments in Pharma.
In the words of Leslie Knope: “Diabetes. Let’s dia-beat-this!”
“Slow and steady” beats “flashy” when it comes to treating cancer, CEO Ben Zeskind says.
Testing the safety and efficacy of medications will still depend on the company and the disease.
Investors were seemingly not satisfied with psilocybin trial results, but the psychedelic health community disagrees.
Oink if you love science!
Digital twins can cut time and costs associated with running drug studies.
On November 25, Cassava Sciences ended a Phase 3 trial of its controversial Alzheimer’s drug, simufilam, following years of scrutiny.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.